Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The potential for targeting the STAT3 pathway as a novel therapy for melanoma.

Literature DB >> 23837753

The potential for targeting the STAT3 pathway as a novel therapy for melanoma.

Gregory B Lesinski.

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2013 PMID： 23837753 PMCID： PMC3801207 DOI： 10.2217/fon.13.83

Source DB: PubMed Journal: Future Oncol ISSN： 1479-6694 Impact factor: 3.404

× No keyword cloud information.

20 in total

Review 1. Targeting STAT3 in cancer: how successful are we?

Authors: Peibin Yue; James Turkson
Journal: Expert Opin Investig Drugs Date: 2009-01 Impact factor: 6.206

2. Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.

Authors: Ling-Yuan Kong; Alexander Gelbard; Jun Wei; Chantal Reina-Ortiz; Yongtao Wang; Eric C Yang; Yared Hailemichael; Izabela Fokt; Arumugam Jayakumar; Wei Qiao; Gregory N Fuller; Willem W Overwijk; Waldemar Priebe; Amy B Heimberger
Journal: Clin Cancer Res Date: 2010-04-13 Impact factor: 12.531

Review 3. Roles of STAT3 defined by tissue-specific gene targeting.

Authors: S Akira
Journal: Oncogene Date: 2000-05-15 Impact factor: 9.867

4. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality.

Authors: K Takeda; K Noguchi; W Shi; T Tanaka; M Matsumoto; N Yoshida; T Kishimoto; S Akira
Journal: Proc Natl Acad Sci U S A Date: 1997-04-15 Impact factor: 11.205

Review 5. Targeting STAT3 affects melanoma on multiple fronts.

Authors: Marcin Kortylewski; Richard Jove; Hua Yu
Journal: Cancer Metastasis Rev Date: 2005-06 Impact factor: 9.264

6. Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor.

Authors: T M Becker; S C Boyd; B Mijatov; K Gowrishankar; S Snoyman; G M Pupo; R A Scolyer; G J Mann; R F Kefford; X D Zhang; H Rizos
Journal: Oncogene Date: 2013-03-04 Impact factor: 9.867

7. Activation of stat3 in human melanoma promotes brain metastasis.

Authors: Tong-xin Xie; Feng-Ju Huang; Kenneth D Aldape; Shin-Hyuk Kang; Mingguang Liu; Jeffrey E Gershenwald; Keping Xie; Raymond Sawaya; Suyun Huang
Journal: Cancer Res Date: 2006-03-15 Impact factor: 12.701

Review 8. STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors: Hua Yu; Drew Pardoll; Richard Jove
Journal: Nat Rev Cancer Date: 2009-11 Impact factor: 60.716

9. Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells.

Authors: Hong Xin; Chunyan Zhang; Andreas Herrmann; Yan Du; Robert Figlin; Hua Yu
Journal: Cancer Res Date: 2009-02-24 Impact factor: 12.701

10. In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses.

Authors: Marcin Kortylewski; Piotr Swiderski; Andreas Herrmann; Lin Wang; Claudia Kowolik; Maciej Kujawski; Heehyoung Lee; Anna Scuto; Yong Liu; Chunmei Yang; Jiehui Deng; Harris S Soifer; Andrew Raubitschek; Stephen Forman; John J Rossi; Drew M Pardoll; Richard Jove; Hua Yu
Journal: Nat Biotechnol Date: 2009-09-13 Impact factor: 54.908

13 in total

Review 1. STAT3 activation in infection and infection-associated cancer.

Authors: Rong Lu; Yong-Guo Zhang; Jun Sun
Journal: Mol Cell Endocrinol Date: 2017-02-20 Impact factor: 4.102

2. Macrophages in skin melanoma-the key element in melanomagenesis.

Authors: Malgorzata Pieniazek; Rafal Matkowski; Piotr Donizy
Journal: Oncol Lett Date: 2018-02-09 Impact factor: 2.967

3. Renalase Expression by Melanoma and Tumor-Associated Macrophages Promotes Tumor Growth through a STAT3-Mediated Mechanism.

Authors: Lindsay Hollander; Xiaojia Guo; Heino Velazquez; John Chang; Robert Safirstein; Harriet Kluger; Charles Cha; Gary V Desir
Journal: Cancer Res Date: 2016-05-09 Impact factor: 12.701

Review 4. Other targeted drugs in melanoma.

Authors: María González-Cao; Jordi Rodón; Niki Karachaliou; Jesús Sánchez; Mariacarmela Santarpia; Santiago Viteri; Sara Pilotto; Cristina Teixidó; Aldo Riso; Rafael Rosell
Journal: Ann Transl Med Date: 2015-10

5. Patient with confirmed LEOPARD syndrome developing multiple melanoma.

Authors: Caroline Colmant; Deborah Franck; Liliane Marot; Gert Matthijs; Yves Sznajer; Sandrine Blomme; Isabelle Tromme
Journal: Dermatol Pract Concept Date: 2018-01-31

6. Inhibition of Jak/STAT signaling reduces the activation of pancreatic stellate cells in vitro and limits caerulein-induced chronic pancreatitis in vivo.

Authors: Hannah M Komar; Gregory Serpa; Claire Kerscher; Erin Schwoegl; Thomas A Mace; Ming Jin; Ming-Chen Yang; Ching-Shih Chen; Mark Bloomston; Michael C Ostrowski; Phil A Hart; Darwin L Conwell; Gregory B Lesinski
Journal: Sci Rep Date: 2017-05-11 Impact factor: 4.379

7. Cytotoxic Activities and Molecular Mechanisms of the Beauvericin and Beauvericin G₁ Microbial Products against Melanoma Cells.

Authors: Haet Nim Lim; Jun-Pil Jang; Hee Jeong Shin; Jae-Hyuk Jang; Jong Seog Ahn; Hye Jin Jung
Journal: Molecules Date: 2020-04-23 Impact factor: 4.411